The four main symptoms of ovarian cancer are persistent bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and needing to urinate more urgently or frequently. The key word is persistent: these symptoms become significant when they occur roughly 12 or more times per month and represent a change from what’s normal for you. Because these overlap with everyday digestive and urinary complaints, ovarian cancer is often caught late, which makes recognizing the pattern early genuinely important.
The Four Core Symptoms
Ovarian cancer has a reputation as a “silent” disease, but it does produce symptoms. They’re just easy to dismiss. The NHS identifies four primary warning signs to watch for:
- A swollen abdomen or persistent bloating that doesn’t come and go with your cycle or diet the way normal bloating does
- Pain or tenderness in your abdomen or pelvis
- Loss of appetite or feeling full after eating very little
- Urinary urgency or frequency, meaning you suddenly need to go more often or more urgently than usual
These symptoms matter when they’re new for you and when they keep happening. Occasional bloating after a big meal is not a red flag. Bloating that shows up most days for several weeks, especially alongside one or more of the other symptoms, is worth investigating.
Other Symptoms to Know
Beyond the four core signs, ovarian cancer can also cause unexplained weight loss, persistent fatigue, back pain, and changes in bowel habits like new or worsening constipation. These are less specific on their own, meaning they have many possible explanations, but in combination with the primary symptoms they strengthen the case for getting checked.
Some people also notice irregular bleeding or changes in their menstrual pattern, though this is less commonly highlighted as a hallmark symptom.
Why These Symptoms Get Overlooked
The biggest challenge with ovarian cancer is that bloating, pelvic discomfort, and urinary changes are incredibly common in everyday life. They overlap with irritable bowel syndrome, urinary tract issues, perimenopause, and simple indigestion. This is exactly why so many cases are diagnosed at an advanced stage.
The overlap with menopause is particularly tricky. The American Cancer Society notes that menopause symptoms can mimic gynecologic cancer symptoms, and ovarian cancer becomes more common with age. Bloating, nausea, and abdominal discomfort during the menopausal transition are easy to write off as hormonal changes when they could signal something more serious.
Ovarian Cancer vs. IBS
Irritable bowel syndrome is one of the most common conditions confused with ovarian cancer, and the distinction matters. A new IBS diagnosis in someone over 50 should always prompt consideration of ovarian cancer, because new-onset IBS at that age is uncommon.
There are practical differences between the two. IBS symptoms tend to be intermittent, coming and going over time. Ovarian cancer symptoms are persistent and progressively worsen. With IBS, bloating typically builds during the day and improves overnight. With ovarian cancer, bloating is often present first thing in the morning. Another useful marker: IBS-related pain usually improves after a bowel movement. Ovarian cancer pain does not. If you’ve had IBS for years and notice your symptoms have changed in character, frequency, or severity, that shift is worth mentioning to your doctor.
Why Early Detection Changes the Outcome
The survival difference between early and late-stage ovarian cancer is dramatic. When caught while still localized to the ovaries, the five-year survival rate is about 92%. Once it has spread to nearby tissues, that drops to around 70%. When it has spread to distant parts of the body, the rate falls to roughly 32%. Most ovarian cancers are currently diagnosed at the distant stage, which is the core reason the disease has a reputation for being so deadly. The cancer itself isn’t uniquely aggressive at all stages. It’s the late detection that drives poor outcomes.
There is currently no reliable routine screening test for ovarian cancer the way mammograms screen for breast cancer or colonoscopies screen for colon cancer. Blood tests that measure a protein called CA-125 and transvaginal ultrasounds can help detect ovarian cancer, but they haven’t proven effective enough as population-wide screening tools. This puts more weight on symptom awareness as the main path to earlier diagnosis.
Who Faces Higher Risk
Most ovarian cancer occurs in people over 50, but it can develop at any age. About 1.1% of women in the general population will develop ovarian cancer in their lifetime. That baseline risk increases substantially with certain inherited gene changes. People who carry a BRCA1 mutation face a 39% to 58% lifetime risk of ovarian cancer. For BRCA2 carriers, the risk is 13% to 29%. If two or more close relatives have had ovarian or breast cancer, genetic counseling can help clarify your personal risk.
Other factors that increase risk include never having been pregnant, starting menstruation early or reaching menopause late, endometriosis, and using hormone replacement therapy for extended periods. Having used oral contraceptives, breastfeeding, and having had pregnancies are all associated with lower risk.
What to Do if You Notice Symptoms
If you’ve been experiencing bloating, pelvic pain, early fullness when eating, or urinary changes most days for three weeks or more, tracking your symptoms before a medical appointment can be genuinely helpful. Note what you’re experiencing, how often, and when it started. Organizations like Target Ovarian Cancer offer free symptom diary tools designed specifically for this purpose.
At your appointment, mention any family history of ovarian or breast cancer. If your symptoms are frequent and persistent, the typical first steps are a CA-125 blood test and an ultrasound of your abdomen and ovaries. These aren’t perfect tests, but they help determine whether further investigation is needed. If your symptoms persist after an initial visit and you haven’t been referred for testing, go back. Persistence on your part can make the difference between an early and a late diagnosis.